Mizuho Securities reduced Albemarle's price target to $140 from $160, maintaining a Neutral rating. The update coincides with announced leadership changes at the company. Downward revisions signal cautious sentiment in the specialty chemicals segment. Investors may weigh potential headwinds against long-term growth prospects. Management transitions could influence strategic direction and execution timelines. Financial outlook adjustments reflect near-term valuation concerns among analysts.
4 articles
Mizuho Securities cut Albemarle's price target to $140 from $160, keeping a Neutral rating. The move aligns with recent leadership updates at the specialty chemicals firm, including Ragnar Udd's appoi
Albemarle Corp. and Chilean union leaders reached a preliminary wage agreement to avert a strike at its Salar de Atacama lithium operation. Final ratification by workers' assembly is still pending.
Albemarle Corp. has appointed Ragnar Udd as its new president and CEO, effective February 1, 2027, succeeding Kent Masters. Udd brings extensive experience from BHP Group in global resources and comme
Albemarle Corp. shares surged over 5% after reporting a quarterly earnings beat driven by recovering lithium prices and strong EV demand. First-quarter net sales rose 33% to $1.43 billion, with adjust
ChemBrief